|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM362124728 |
| 003 |
DE-627 |
| 005 |
20250305062633.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202301035
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1206.xml
|
| 035 |
|
|
|a (DE-627)NLM362124728
|
| 035 |
|
|
|a (NLM)37715333
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Jiang, Qiao
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a DNA Origami
|b From Molecular Folding Art to Drug Delivery Technology
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 29.05.2024
|
| 500 |
|
|
|a Date Revised 30.05.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2023 Wiley‐VCH GmbH.
|
| 520 |
|
|
|a DNA molecules that store genetic information in living creatures can be repurposed as building blocks to construct artificial architectures, ranging from the nanoscale to the microscale. The precise fabrication of self-assembled DNA nanomaterials and their various applications have greatly impacted nanoscience and nanotechnology. More specifically, the DNA origami technique has realized the assembly of various nanostructures featuring rationally predesigned geometries, precise addressability, and versatile programmability, as well as remarkable biocompatibility. These features have elevated DNA origami from academic interest to an emerging class of drug delivery platform for a wide range of diseases. In this minireview, the latest advances in the burgeoning field of DNA-origami-based innovative platforms for regulating biological functions and delivering versatile drugs are presented. Challenges regarding the novel drug vehicle's safety, stability, targeting strategy, and future clinical translation are also discussed
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a DNA origami
|
| 650 |
|
4 |
|a disease treatment
|
| 650 |
|
4 |
|a drug delivery
|
| 650 |
|
4 |
|a self‐assembly
|
| 650 |
|
7 |
|a DNA
|2 NLM
|
| 650 |
|
7 |
|a 9007-49-2
|2 NLM
|
| 650 |
|
7 |
|a Drug Carriers
|2 NLM
|
| 700 |
1 |
|
|a Shang, Yingxu
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Xie, Yiming
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ding, Baoquan
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 36(2024), 22 vom: 04. Mai, Seite e2301035
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnas
|
| 773 |
1 |
8 |
|g volume:36
|g year:2024
|g number:22
|g day:04
|g month:05
|g pages:e2301035
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202301035
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 36
|j 2024
|e 22
|b 04
|c 05
|h e2301035
|